MBrace Therapeutics is dedicated to transforming cancer treatment through innovative discovery, aiming to translate research into transformative therapies for cancer patients. The team comprises experienced experts across cancer drug development, working together to offer new and improved treatment options. MBrace's approach integrates the expertise of researchers, the needs of patients, the guidance of physicians, and the team's dedication, fostering advancements in cancer therapeutics. Each team member's personal experience with cancer underpins their commitment to patient care, driving the development of novel treatment options.
MBRace Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own MBRace Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
MBRace Therapeutics is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.